{"id":54350,"date":"2023-02-28T23:03:17","date_gmt":"2023-02-28T22:03:17","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/"},"modified":"2023-02-28T23:03:17","modified_gmt":"2023-02-28T22:03:17","slug":"puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/","title":{"rendered":"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will attend Cowen\u2019s 43rd<\/sup> Annual Health Care Conference, which will be held March 6 \u2013 8, 2023 at the Boston Marriott Copley Place in Boston. Mr. Auerbach will participate in a Breast and Lung Cancer Panel Discussion <\/i>on March 7 at 10:30 a.m. ET.\n<\/p>\n

<\/a><\/p>\n

\nA live webcast of the Breast and Lung Cancer Panel Discussion <\/i>will be available at https:\/\/wsw.com\/webcast\/cowen132\/panel8\/2250192<\/a>, and a replay will be available on Puma\u2019s website for 30 days following the presentation at https:\/\/www.pumabiotechnology.com\/ir_events.html<\/a>.\n<\/p>\n

\nAbout Puma Biotechnology<\/b>\n<\/p>\n

\nPuma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Neratinib, oral was approved by the U.S. Food and Drug Administration in 2017 for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed\/amplified breast cancer, following adjuvant trastuzumab-based therapy, and is marketed in the United States as NERLYNX\u00ae (neratinib) tablets. In February 2020, NERLYNX was also approved by the FDA in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer who have received two or more prior anti-HER2-based regimens in the metastatic setting. NERLYNX was granted marketing authorization by the European Commission in 2018 for the extended adjuvant treatment of adult patients with early stage hormone receptor-positive HER2-overexpressed\/amplified breast cancer and who are less than one year from completion of prior adjuvant trastuzumab-based therapy. NERLYNX is a registered trademark of Puma Biotechnology, Inc.\n<\/p>\n

\nIn September 2022, Puma entered into an exclusive license agreement for the development and commercialization of the anti-cancer drug alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Initially, Puma intends to focus the development of alisertib on the treatment of small cell lung cancer and breast cancer.\n<\/p>\n

\nFurther information about Puma Biotechnology may be found at https:\/\/www.pumabiotechnology.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAlan H. Auerbach or Mariann Ohanesian, Puma Biotechnology, Inc., +1 424 248 6500
\n
info@pumabiotechnology.com<\/a>
ir@pumabiotechnology.com<\/a>\n<\/p>\n

\nDavid Schull, Russo Partners, +1 212 845 4200
\n
david.schull@russopartnersllc.com<\/a>
olipriya.das@russopartnersllc.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will attend Cowen\u2019s 43rd Annual Health Care Conference, which will be held March 6 \u2013 8, 2023 at the Boston Marriott Copley Place in Boston. Mr. Auerbach will participate in a … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54350","6":"format-standard","7":"category-industry"},"yoast_head":"\nPuma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will attend Cowen\u2019s 43rd Annual Health Care Conference, which will be held March 6 \u2013 8, 2023 at the Boston Marriott Copley Place in Boston. Mr. Auerbach will participate in a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-28T22:03:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230228006332\/en\/1725955\/21\/4357884cpuma_logo_JPEG.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference\",\"datePublished\":\"2023-02-28T22:03:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/\"},\"wordCount\":395,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006332\\\/en\\\/1725955\\\/21\\\/4357884cpuma_logo_JPEG.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/\",\"name\":\"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006332\\\/en\\\/1725955\\\/21\\\/4357884cpuma_logo_JPEG.jpg\",\"datePublished\":\"2023-02-28T22:03:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006332\\\/en\\\/1725955\\\/21\\\/4357884cpuma_logo_JPEG.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230228006332\\\/en\\\/1725955\\\/21\\\/4357884cpuma_logo_JPEG.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/","og_locale":"en_US","og_type":"article","og_title":"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will attend Cowen\u2019s 43rd Annual Health Care Conference, which will be held March 6 \u2013 8, 2023 at the Boston Marriott Copley Place in Boston. Mr. Auerbach will participate in a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-28T22:03:17+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230228006332\/en\/1725955\/21\/4357884cpuma_logo_JPEG.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference","datePublished":"2023-02-28T22:03:17+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/"},"wordCount":395,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230228006332\/en\/1725955\/21\/4357884cpuma_logo_JPEG.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/","url":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/","name":"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230228006332\/en\/1725955\/21\/4357884cpuma_logo_JPEG.jpg","datePublished":"2023-02-28T22:03:17+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230228006332\/en\/1725955\/21\/4357884cpuma_logo_JPEG.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230228006332\/en\/1725955\/21\/4357884cpuma_logo_JPEG.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/puma-biotechnology-to-participate-in-a-panel-discussion-at-cowens-43rd-annual-health-care-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Puma Biotechnology to Participate in a Panel Discussion at Cowen\u2019s 43rd Annual Health Care Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54350"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54350\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}